Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group is a research paper published in Journal of Clinical Oncology (2023). On theSindex it has a DataRank of 0.507. It has been cited 10 times, with 10 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.147
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 10 citers.
NCI NIH HHS
Grant: U10 CA098413
NCI NIH HHS
Grant: U24 CA196173
NCI NIH HHS
Grant: U24 CA180803
NCI NIH HHS
Grant: U10 CA180899
NCI NIH HHS
Grant: U10 CA029511
NCI NIH HHS
Grant: U10 CA098543
NCI NIH HHS
Grant: U10 CA180886
FWCI
1.66
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals